<![CDATA[Pivotal Trials: Efficacy and Safety of Dextromethorphan-Bupropion in Agitation]]>
The panel walks through the pivotal trial data behind one of the two on-label agents, dextromethorphan-bupropion, beginning with a five-week, placebo-controlled, multicenter short-term trial. Enrolled outpatients had a clinical Alzheimer's dementia …